Nov 10, 2015 8:30 am EST CymaBay Therapeutics Announces the Initiation of a Phase 2 Study of MBX-8025 in Patients With Primary Biliary Cholangitis/Cirrhosis
Nov 05, 2015 8:30 am EST CymaBay Therapeutics to Present Results From Two Arhalofenate Phase 2 Studies at the American College of Rheumatology (ACR) Annual Meeting, November 6 - 11
Nov 04, 2015 8:30 am EST CymaBay to Announce Third Quarter 2015 Financial Results on Thursday, November 12
Oct 08, 2015 4:01 pm EDT CymaBay Announces the Appointment of Robert J. Wills, Ph.D., as Chairman of the Board of Directors
Sep 03, 2015 8:00 am EDT CymaBay Therapeutics to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
Aug 06, 2015 8:00 am EDT CymaBay Strengthens the Intellectual Property of Arhalofenate With Issuance of Two New Patents
Aug 03, 2015 8:00 am EDT CymaBay to Announce Second Quarter 2015 Financial Results on Monday, August 10